Nucleic Acid Testing (NAT) Market research report by Delvens focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity.
The global Nucleic Acid Testing (NAT) Market size is projected to reach a CAGR of 7.7% from 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/nucleic-acid-testing-market
Nucleic acid testing (NAT) refers to a molecular technique for screening viruses, bacteria or pathogenic nucleic acid in the blood, tissue or urine of the patient. It is conducted for forensic testing and to diagnose transfusion-transmitted infections, genetic diseases and cancer. It involves sample pooling through nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection. The testing involves kits and consumables for performing polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and NA sequence-based amplification (NASBA) processes.
Rising usage of nucleic acid tests for the treatment of genetically related diseases, cancerous diseases, and infectious diseases caused by bacteria or viruses is anticipated to spur their demand worldwide. Apart from this, extensive use utilized for paternity testing/HLA typing and forensic testing will aid the expansion of the nucleic acid testing market in the coming years.
Regional Analysis
North America to Dominate the Market
North America holds a dominant position in the nucleic acid testing market. This is owing to increasing research and development studies by various government and pharmaceutical organizations in infectious disease and cancer diagnosis in North America.
Furthermore, high prevalence and awareness of cancer among people, in turn opting for early detection of cancer, is expected to aid in the growth of the nucleic acid testing market in this region.
Competitive Landscape
• Abbott Laboratories
• Beckman Coulter, Inc.
• Becton
• Dickinson and Company
• BioMérieux SA
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Grifols S.A.
• Illumina, Inc.
• Novartis Ag
• Qiagen N.V.
• Quest Diagnostics Incorporated
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/nucleic-acid-testing-market
Recent Developments
In December 2021, Roche, a multinational healthcare company based in Switzerland, introduced its latest infectious disease tests on a novel molecular laboratory instrument named cobas 5800 System in countries accepting the CE mark.
11 April 2022 — Abbott, the global healthcare leader, has launched Arachitol Gummies in India, a new fruit-flavoured product for kids and adults. Arachitol Gummies are a dietary supplement that helps maintain required levels of Vitamin D sustainably.
Nucleic Acid Testing (NAT) Market is segmented into various segments such as product type, indication, end user and region:
On the basis of product type
• Nucleic Acid Test Kits
• Consumables
On the basis of the indication
• Infectious Disease
• Cancer
• Forensic Testing
• Personalized Medicine
• Others
On the basis of end-use
• Hospitals & Clinics
• Pathology Laboratories
• Academic & Research Organization.
On the basis of region
• Asia Pacific
• North America
• Europe
• South America
• Middle East & Africa
Access Full Report: https://www.delvens.com/report/nucleic-acid-testing-market
In addition to the market data for Nucleic Acid Testing (NAT) Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.
Frequently Asked Questions
What are the years considered to study Nucleic Acid Testing (NAT) Market intelligence report?
The Nucleic Acid Testing (NAT) Market is studied from 2023-2030.
What is the compound annual growth rate (CAGR) of the Nucleic Acid Testing (NAT) Market?
The Nucleic Acid Testing (NAT) Market is growing at a CAGR of 7.7% during the forecast period.
Which region holds the largest market share in Nucleic Acid Testing (NAT) Market?
North America holds the highest share in 2022 for Nucleic Acid Testing (NAT) Market.
For More Inquiry Contact us:
Digital Pathology Market size is 799.296 million USD in 2022 and is projected to reach a CAGR of 8.6% from 2023-2030.
Functional Service Provider (FSP) Market size is projected to reach a CAGR of 8.7% from 2023-2030.
Hormone Replacement Therapy (HRT) Market size is projected to reach a CAGR of 6.3% from 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
[email protected]